Medigen Biotechnology

Medigen Biotechnology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medigen Biotechnology (3176.TWO) as of Nov 4, 2026 is -105.03 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -202.36 M TWD — a change of -48.10% (higher).

EBITDA

-105.03 MTWD

YoY

-48.10%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medigen Biotechnology is 2025 -105.03 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medigen Biotechnology was 2024 -202.36 M TWD. It decreases by -48.10% higher compared to the previous year.

The Medigen Biotechnology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-722.86 M TWD
Jan 1, 2019
-727.34 M TWD
Jan 1, 2020
-878.12 M TWD
Jan 1, 2021
822.30 M TWD
Jan 1, 2022
-1.65 B TWD
Jan 1, 2023
-1.22 B TWD
Jan 1, 2024
-202.36 M TWD
Jan 1, 2025
-105.03 M TWD
The Medigen Biotechnology EBITDA history
YEAREBITDAYoY
-105.03 MTWD-48.10%
-202.36 MTWD-83.45%
-1.22 BTWD-25.99%
-1.65 BTWD-300.97%
822.30 MTWD-193.64%
-878.12 MTWD+20.73%
-727.34 MTWD+0.62%
-722.86 MTWD+13.52%
-636.79 MTWD-26.83%
-870.23 MTWD+21.43%
-716.67 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medigen Biotechnology Stock analysis

What does Medigen Biotechnology do? Medigen Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigen Biotechnology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medigen Biotechnology is -105.03 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medigen Biotechnology changed from -202.36 M TWD to -105.03 M TWD, representing a -48.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medigen Biotechnology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medigen Biotechnology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medigen Biotechnology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medigen Biotechnology